BHARAT IMMUNOLOGICALS Beta

BHARAT IMMUNOLOGICALS beta fundamental analysis lookup allows you to check this and other indicators for BHARAT IMMUNOLOGICALS BIOLOG or any other equity instrument. You can also select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools
Symbol
Refresh

BHARAT IMMUNOLOGICALS Beta Analysis

Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of financial instrument to the financial market in which this instrument is traded. For example if Beta of equity is 2, it will be expected to significantly outperform market when market is going up and significantly underperform when market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns during over time.
Beta 
 = 
Covariance 
Variance 
More About Beta | All Equity Analysis
BHARAT IMMUNOLOGICALS Beta  =
0.82
BHARAT IMMUNOLOGICALS ValuationFundamentalsBuy or Sell

About Beta

In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.Compare to competition
In accordance with recently published financial statements BHARAT IMMUNOLOGICALS BIOLOG has Beta of 0.82. This is 4.65% lower than that of the Healthcare sector, and 41.01% lower than that of Biotechnology industry, The Beta for all stocks is 646.67% lower than the firm.

Did you try this?

Run Piotroski F Score Now

   

Piotroski F Score

Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
All  Next Launch Module
As returns on market increase, BHARAT IMMUNOLOGICALS returns are expected to increase less than the market. However during bear market, the loss on holding BHARAT IMMUNOLOGICALS will be expected to be smaller as well.

BHARAT IMMUNOLOGICALS current financial ratios



 
Search macroaxis.com